AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

Q: What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share in Q2 2021?

222 institutional investors reported FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 03152W109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 311,669,400
Total 13F shares: 276,914,599
Share change: +959,279
Total reported value: $2,669,802,857
Put/Call ratio: 33%
Price per share: $9.64
Number of holders: 222
Value change: +$6,810,492
Number of buys: 112
Number of sells: 113

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	7.8%	24,387,053	$240,945,000	—	31 Mar 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	7.3%	22,861,329	$225,870,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	6.9%	21,521,879	$212,636,000	—	31 Mar 2021	13F
Redmile Group, LLC	13F	Company	6.8%	21,114,114	$208,607,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4.5%	14,107,972	$139,386,000	—	31 Mar 2021	13F
Avoro Capital Advisors LLC	13F	Company	3.9%	12,250,000	$121,030,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	3.8%	11,879,824	$117,373,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	3.2%	9,966,548	$98,470,000	—	31 Mar 2021	13F
Palo Alto Investors LP	13F	Company	3.1%	9,761,043	$96,439,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	3.1%	9,536,942	$94,225,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.9%	8,984,055	$88,762,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	2.3%	7,313,927	$72,261,000	—	31 Mar 2021	13F
JENNISON ASSOCIATES LLC	13F	Company	1.8%	5,733,479	$56,647,000	—	31 Mar 2021	13F
MACQUARIE GROUP LTD	13F	Company	1.8%	5,694,195	$56,258,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	1.4%	4,414,976	$43,620,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	4,375,227	$43,227,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	1.2%	3,750,000	$37,050,000	—	31 Mar 2021	13F
Fiera Capital Corp	13F	Company	1%	3,206,490	$31,680,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.95%	2,960,716	$29,253,000	—	31 Mar 2021	13F
Clearbridge Investments, LLC	13F	Company	0.93%	2,894,879	$28,601,000	—	31 Mar 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.87%	2,698,497	$26,661,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.76%	2,354,088	$23,258,000	—	31 Mar 2021	13F
Boxer Capital, LLC	13F	Company	0.75%	2,325,000	$22,971,000	—	31 Mar 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.74%	2,305,432	$22,778,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.73%	2,282,406	$22,550,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.7%	2,188,692	$21,624,000	—	31 Mar 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.68%	2,130,000	$21,044,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.67%	2,085,672	$20,606,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.66%	2,064,552	$20,397,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.65%	2,020,527	$19,963,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.65%	2,011,327	$19,872,000	—	31 Mar 2021	13F
Novo Holdings A/S	13F	Company	0.63%	1,962,880	$19,393,000	—	31 Mar 2021	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.6%	1,861,400	$18,391,000	—	31 Mar 2021	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.57%	1,766,704	$17,455,000	—	31 Mar 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.57%	1,761,865	$17,407,000	—	31 Mar 2021	13F
Hood River Capital Management LLC	13F	Company	0.54%	1,692,241	$16,719,000	—	31 Mar 2021	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.52%	1,616,670	$16,263,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.5%	1,553,776	$15,351,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.2%	615,124	$13,643,000	—	31 Mar 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.4%	1,260,156	$12,450,000	—	31 Mar 2021	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	0.37%	1,160,724	$11,468,000	—	31 Mar 2021	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.37%	1,145,594	$11,318,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.34%	1,047,164	$10,345,000	—	31 Mar 2021	13F
Rock Springs Capital Management LP	13F	Company	0.32%	1,012,506	$10,004,000	—	31 Mar 2021	13F
Grosvenor Holdings, L.L.C.	13F	Company	0.31%	971,866	$9,602,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.31%	957,077	$9,456,000	—	31 Mar 2021	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.25%	791,367	$7,819,000	—	31 Mar 2021	13F
Fairmount Funds Management LLC	13F	Company	0.25%	788,980	$7,795,000	—	31 Mar 2021	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.25%	779,323	$7,699,711	—	31 Mar 2021	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.23%	728,241	$7,195,000	—	31 Mar 2021	13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q2 2021

As of 30 Jun 2021, AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by 222 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 276,914,599 shares. The largest 10 holders included VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Avoro Capital Advisors LLC, MORGAN STANLEY, Palo Alto Investors LP, and STATE STREET CORP. This page lists 222 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

241

Q2 2021 holders

222

Holder diff

-19

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.